QSER1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.286200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.382800E-01
Normal-vs-Stage2
7.830600E-01
Normal-vs-Stage3
2.310000E-02
Normal-vs-Stage4
6.309200E-01
Stage1-vs-Stage2
8.509000E-01
Stage1-vs-Stage3
1.311520E-02
Stage1-vs-Stage4
4.119800E-01
Stage2-vs-Stage3
1.022640E-04
Stage2-vs-Stage4
2.933200E-01
Stage3-vs-Stage4
1.011020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.907600E-01
Normal-vs-AfricanAmerican
7.621800E-01
Normal-vs-Asian
3.727800E-01
Caucasian-vs-AfricanAmerican
2.508200E-01
Caucasian-vs-Asian
4.215800E-01
AfricanAmerican-vs-Asian
1.717970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.719600E-01
Normal-vs-Female
6.783400E-01
Male-vs-Female
8.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.518200E-01
Normal-vs-Age(41-60Yrs)
8.306400E-01
Normal-vs-Age(61-80Yrs)
5.350400E-01
Normal-vs-Age(81-100Yrs)
2.653600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.358800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.554200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.417600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.235400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.721900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.797400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.035000E-01
Normal-vs-Daily Drinker
2.774400E-01
Normal-vs-Weekly Drinker
3.342600E-01
Normal-vs-Occasional Drinker
7.814800E-01
Normal-vs-Social Drinker
9.812400E-01
Non Drinker-vs-Daily Drinker
3.962600E-01
Non Drinker-vs-Weekly Drinker
5.848400E-01
Non Drinker-vs-Occasional Drinker
1.108190E-01
Non Drinker-vs-Social Drinker
2.890600E-01
Daily Drinker-vs-Weekly Drinker
8.578600E-01
Daily Drinker-vs-Occasional Drinker
4.889800E-02
Daily Drinker-vs-Social Drinker
1.044630E-01
Weekly Drinker-vs-Occasional Drinker
7.731600E-02
Weekly Drinker-vs-Social Drinker
2.025400E-01
Occasional Drinker-vs-Social Drinker
6.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.533210E-01
Normal-vs-Grade 2
3.593800E-02
Normal-vs-Grade 3
2.897800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.062100E-02
Grade 1-vs-Grade 3
2.205800E-02
Grade 1-vs-Grade 4
1.533210E-01
Grade 2-vs-Grade 3
3.036200E-01
Grade 2-vs-Grade 4
3.593800E-02
Grade 3-vs-Grade 4
2.897800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.530400E-01
Normal-vs-NonDiabetic
6.922600E-01
Diabetic-vs-NonDiabetic
2.963600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.325800E-01
Normal-vs-NoPancreatitis
6.793200E-01
Pancreatitis-vs-NoPancreatitis
6.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.107800E-01
Normal-vs-N1
8.149600E-01
N0-vs-N1
3.630800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.374000E-01
Normal-vs-TP53-NonMutant
8.201400E-01
TP53-Mutant-vs-TP53-NonMutant
1.479780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
